P. Rosenthal, M. Ruiz, E. Sokal, E. Sturm, W. van der Woerd, H. J. Verkade, A. Wehrman, C. Clemson, Q. Yu, Q. Ni, J. Ruvido, S. Manganaro, J. P. Mattsson, P. Czubkowski

C17 Efficacy and safety of odevixibat in patients with alagille syndrome: top-line results from assert, a phase 3, double-blind, randomized, placebo-controlled study

EFFICACY AND SAFETY OF ODEVIXIBAT IN PATIENTS WITH ALAGILLE SYNDROME: INTERIM RESULTS FROM THE OPEN-LABEL, PHASE 3 ASSERT-EXT STUDY